Creating Miniantibodies to Study Autoimmune Diseases
Author Information
Author(s): Di Niro Roberto, Ziller Federica, Florian Fiorella, Crovella Sergio, Stebel Marco, Bestagno Marco, Burrone Oscar, Bradbury Andrew RM, Secco Paola, Marzari Roberto, Sblattero Daniele
Primary Institution: University of Trieste
Hypothesis
Can miniantibodies specific to tissue transglutaminase be effectively produced for in vivo studies of autoimmune diseases?
Conclusion
The study successfully demonstrated a method for in vivo expression of miniantibodies specific to transglutaminase, which can help in understanding autoimmune diseases.
Supporting Evidence
- The miniantibodies were secreted efficiently and retained their reactivity to the antigen.
- Stable cell lines were established for miniantibody production.
- Minibodies showed detectable serum levels in mice without inducing a significant immune response.
Takeaway
The researchers made tiny antibodies that can help study diseases where the body attacks itself, like Celiac Disease, and found they work well in mice.
Methodology
The study involved engineering miniantibodies from anti-tTG scFv and testing their expression and functionality in mice.
Limitations
The expression period of the miniantibodies is relatively short compared to the long-term nature of autoimmune diseases.
Participant Demographics
Eight female BALB/c mice were used for the in vivo studies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website